- Mycronic’s third-quarter EBIT (Earnings Before Interest and Taxes) was reported at SEK 547 million.
- This EBIT figure exceeded market expectations, which were SEK 444.3 million.
- The company’s net sales for the third quarter reached SEK 1.78 billion.
- Net sales also beat estimates, which were anticipated at SEK 1.58 billion.
- Total orders for the third quarter amounted to SEK 1.46 billion.
- Current analyst sentiment includes 2 buy recommendations, 0 hold recommendations, and 1 sell recommendation.
A look at Mycronic AB Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 2 | |
Dividend | 2 | |
Growth | 4 | |
Resilience | 5 | |
Momentum | 3 | |
OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Mycronic AB shows a promising long-term outlook. With a growth score of 4 and a resilience score of 5, the company demonstrates strong potential for expansion and a solid ability to withstand economic challenges. This indicates a positive trajectory for Mycronic AB in terms of both development and stability.
While the value and dividend scores stand at 2, indicating some room for improvement in these areas, the momentum score of 3 suggests a steady pace of advancement. Overall, Mycronic AB, a computer technology company specializing in laser writers and electronics industry equipment, appears well-positioned for sustained growth and success in the foreseeable future.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars